Earnings Per Share, Diluted of IDEAYA Biosciences, Inc. from 31 Dec 2020 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD/shares
- Description
- The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
- Summary
-
IDEAYA Biosciences, Inc. quarterly and annual Earnings Per Share, Diluted in USD/shares history and change rate from 31 Dec 2020 to 31 Dec 2025.
- IDEAYA Biosciences, Inc. Earnings Per Share, Diluted for the quarter ending 31 Dec 2025 was -0.91, a 41% increase year-over-year.
- IDEAYA Biosciences, Inc. Earnings Per Share, Diluted for the twelve months ending 31 Dec 2025 was -1.28, a 62% increase year-over-year.
- IDEAYA Biosciences, Inc. annual Earnings Per Share, Diluted for 2025 was -1.28, a 62% increase from 2024.
- IDEAYA Biosciences, Inc. annual Earnings Per Share, Diluted for 2024 was -3.36, a 71% decline from 2023.
- IDEAYA Biosciences, Inc. annual Earnings Per Share, Diluted for 2023 was -1.96, a 38% decline from 2022.
- Source SEC data
- View on sec.gov
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Change (%)
IDEAYA Biosciences, Inc. Quarterly Earnings Per Share, Diluted (USD/shares)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -1.28 | -0.91 | +0.64 | +41% | 01 Oct 2025 | 31 Dec 2025 | 10-K | 17 Feb 2026 | 2025 | FY |
| Q3 2025 | -1.92 | 1.33 | +1.93 | 01 Jul 2025 | 30 Sep 2025 | 10-Q | 04 Nov 2025 | 2025 | Q3 | |
| Q2 2025 | -3.85 | -0.88 | -0.2 | -29% | 01 Apr 2025 | 30 Jun 2025 | 10-Q | 05 Aug 2025 | 2025 | Q2 |
| Q1 2025 | -3.65 | -0.82 | -0.29 | -55% | 01 Jan 2025 | 31 Mar 2025 | 10-Q | 06 May 2025 | 2025 | Q1 |
| Q4 2024 | -3.36 | -1.55 | -1.04 | -204% | 01 Oct 2024 | 31 Dec 2024 | 10-K | 17 Feb 2026 | 2025 | FY |
| Q3 2024 | -2.32 | -0.6 | -0.14 | -30% | 01 Jul 2024 | 30 Sep 2024 | 10-Q | 04 Nov 2025 | 2025 | Q3 |
| Q2 2024 | -2.18 | -0.68 | -0.18 | -36% | 01 Apr 2024 | 30 Jun 2024 | 10-Q | 05 Aug 2025 | 2025 | Q2 |
| Q1 2024 | -2 | -0.53 | -0.04 | -8.2% | 01 Jan 2024 | 31 Mar 2024 | 10-Q | 06 May 2025 | 2025 | Q1 |
| Q4 2023 | -1.96 | -0.51 | +0.02 | +3.8% | 01 Oct 2023 | 31 Dec 2023 | 10-K | 17 Feb 2026 | 2025 | FY |
| Q3 2023 | -1.98 | -0.46 | -0.5 | -1250% | 01 Jul 2023 | 30 Sep 2023 | 10-Q | 04 Nov 2024 | 2024 | Q3 |
| Q2 2023 | -1.48 | -0.5 | +0.07 | +12% | 01 Apr 2023 | 30 Jun 2023 | 10-Q | 06 Aug 2024 | 2024 | Q2 |
| Q1 2023 | -1.55 | -0.49 | -0.13 | -36% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 07 May 2024 | 2024 | Q1 |
| Q4 2022 | -1.42 | -0.53 | 01 Oct 2022 | 31 Dec 2022 | 10-K | 18 Feb 2025 | 2024 | FY | ||
| Q3 2022 | 0.04 | +0.35 | 01 Jul 2022 | 30 Sep 2022 | 10-Q | 07 Nov 2023 | 2023 | Q3 | ||
| Q2 2022 | -0.57 | -0.24 | -73% | 01 Apr 2022 | 30 Jun 2022 | 10-Q | 10 Aug 2023 | 2023 | Q2 | |
| Q1 2022 | -0.36 | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 09 May 2023 | 2023 | Q1 | |||
| Q3 2021 | -0.31 | 01 Jul 2021 | 30 Sep 2021 | 10-Q | 08 Nov 2022 | 2022 | Q3 | |||
| Q2 2021 | -0.33 | 01 Apr 2021 | 30 Jun 2021 | 10-Q | 15 Aug 2022 | 2022 | Q2 |
IDEAYA Biosciences, Inc. Annual Earnings Per Share, Diluted (USD/shares)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | -1.28 | +2.08 | +62% | 01 Jan 2025 | 31 Dec 2025 | 10-K | 17 Feb 2026 | 2025 | FY |
| 2024 | -3.36 | -1.4 | -71% | 01 Jan 2024 | 31 Dec 2024 | 10-K | 17 Feb 2026 | 2025 | FY |
| 2023 | -1.96 | -0.54 | -38% | 01 Jan 2023 | 31 Dec 2023 | 10-K | 17 Feb 2026 | 2025 | FY |
| 2022 | -1.42 | -0.01 | -0.71% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 18 Feb 2025 | 2024 | FY |
| 2021 | -1.41 | -0.01 | -0.71% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 20 Feb 2024 | 2023 | FY |
| 2020 | -1.4 | 01 Jan 2020 | 31 Dec 2020 | 10-K | 07 Mar 2023 | 2022 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.